Pathophysiological features of development, clinical features and treatment of malignant glaucoma

Cover Page

Cite item

Full Text

Abstract

Malignant glaucoma is a difficult task for an ophthalmologist in the treatment process. This is a multifactorial condition that occurs in anatomically predisposed eyes. Malignant glaucoma remains one of the most severe clinical forms of glaucoma requiring timely diagnosis and immediate treatment. Diagnostic issues, pathophysiological mechanisms of development and methods of treatment are still controversial. The diagnosis of malignant glaucoma is often late due to similarity with some other pathological conditions. In many cases malignant glaucoma is resistant to medication and laser treatment. Surgical treatment of malignant glaucoma is complex and not always effective. The review discusses the possible pathophysiological mechanisms of development, diagnostic methods of research, as well as the applied conservative, laser and surgical methods of treatment of malignant glaucoma.

About the authors

Olga A. Kiseleva

Helmholtz national medical research center of eye diseases

Email: kiseleva-glaucoma@yandex.ru
SPIN-code: 2648-0159

MD, Head of Glaucoma Department

Russian Federation, 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062

Srbui M. Kosakyan

Helmholtz national medical research center of eye diseases

Email: kosakyan@yandex.ru

PhD, Doctor, Glaucoma Department

Russian Federation, 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062

Liya V. Yakubova

Helmholtz national medical research center of eye diseases

Email: yakoubova@yandex.ru

PhD, Senior Research Worker, Glaucoma Department

Russian Federation, 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062

Alexander M. Bessmertny

Helmholtz national medical research center of eye diseases

Author for correspondence.
Email: bessmeram@gmail.com
SPIN-code: 9883-6509

MD, Senior Research Worker, Glaucoma Department

Russian Federation, 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062

Lubov’ V. Vasilenkova

Helmholtz national medical research center of eye diseases

Email: glaucoma@igb.ru

PhD, Research Worker, Glaucoma Department

Russian Federation, 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062

References

  1. Von Graefe A. Beitrage zur pathologie und terapie des glaucoms. [Contributions to the pathology and therapy of the glaucomas. (In German)]. Arch Ophthalmol. 1869;15(3):108-252.
  2. Muqit MM, Menage MJ. Malignant glaucoma after phacoemulsification: treatment with diode laser cyclophotocoagulation. J Cataract Refract Surg. 2007;33(1):130-2. https://doi.org/10.1016/j.jcrs.2006.07.041.
  3. Simmons RJ. Malignant glaucoma. Br J Ophthalmol. 1972;56(3):263-272. https://doi.org/10.1136/bjo.81.2.163.
  4. Киселева О.А., Косакян С.М., Якубова Л.В., и др. К вопросу о патогенезе злокачественной глаукомы // Сб. науч. трудов науч. – практ. конф. с междунар. участием: Х Российский общенациональный офтальмологический форум; Москва, октябрь 3–5, 2017 / Под ред. В.В. Нероева. – М.: Апрель, 2017. – С. 467–471. [Kiseleva OA, Kosakyan SM, Yakubova LV, et al. To the question of the pathogenesis of malignant glaucoma. In: (Collection of scientific articles) VIII Russian national ophthalmological forum; Moscow, October, 3-5, 2017. Ed. by V.V. Neroyev. Moscow: Aprel’; 2017. Р. 467-471. (In Russ.)]
  5. Rękas М, Krix-Jachym К. Malignant glaucoma. Glaucoma – basic and clinical aspects. IntechOpen; 2012. Р. 422-437. https://doi.org/10.5772/53979.
  6. Shahid H, Salmon JF, Malignant Glaucoma: a review of the modern literature. J Ophthalmol. 2012,2012:6. https://doi.org/10.1155/2012/852659.
  7. Cyrlin MN. Malignant glaucoma. In: Samples JR, Schacknow PN, ed. Clinical Glaucoma Care. NY: Springer; 2014. P. 323-334.
  8. Boke W, Teichmann KD, Junge W. [Experiences with ciliary block («malignant») glaucoma (author’s transl) (In German)]. Klin Monbl Augenheilkd. 1980;177(4):407-416. https://doi.org/10.1055/s-2008-1057662.
  9. Levene R. Malignant glaucoma: proposed definition and classification. In: Shields MB, Pollack I, Kolker A. Perspectives in glaucoma. Transactions of the first scientific meeting of the American Glaucoma Society. Thorofare, NJ, Slack; 1988. Р. 243-350.
  10. Simmons RJ, Dallow LR. Primary angle closure glaucoma. In: Duane TD (ed). Clinical ophthalmology. Vol. 3, Chap. 53. Philadelphia, Harper and Row; 1983. Р. 27-31.
  11. Luntz MH, Rosenblatt M. Malignant glaucoma. Surv Ophthalmol. 1987;32(2):73-93. https://doi.org/10.1016/0039-6257(87)90101-9.
  12. Burgansky-Eliash Z, Ishikawa H, Schuman JS. Hypotonous malignant glaucoma: aqueous misdirection with low intraocular pressure. Ophthalmic Surg Lasers Imaging. 2008;39(2):155-159. https://doi.org/:10.3928/15428877-20080301-03.
  13. Pons МЕ, Roy H (chief ed.). Malignant glaucoma [Internet]. Medscape; 2018 [cited 2018 September 20]. Available from: emedicine.medscape.com/article/1205609-print.
  14. Krix-Jachym K, Rękas M, Zarnowski T. Risk factors of malignant glaucoma occurrence after glaucoma surgery. J Ophthalmol. 2017;(2):1-6. https://doi.org/10.1155/2017/9616738.
  15. Brooks AM, Harper CA, Gillies WE. Occurrence of malignant glaucoma after laser iridotomy. Br J Ophthalmol. 1989;73(8):617-620. https://doi.org/10.1136/bjo.73.8.617.
  16. Ефимова М.Н. Злокачественная глаукома: диагностика, клиника, лечение // Глаукома. – 2002. – № 1. – C. 53–60. [Efimova MN. Malignant glaucoma: diagnosis, clinic, treatment. Glaucoma. 2002;(1):53-60. (In Russ.)]
  17. Lynch MG, Brown RH, Michels RG, et al. Surgical vitrectomy for pseudophakic malignant glaucoma. Am J Ophthalmol. 1986;102(2): 149-153. https://doi.org/10.1016/0002-9394 (86)90135-2.
  18. Mastropasqua L, Ciancaglini M, Carpineto P, et al. Aqueous misdirection syndrome: a complication of YAG posterior capsulotomy. J Cataract Refract Surg. 1994;20(5):563-565. https://doi.org/10.1016/s0886-3350(13)80238-6.
  19. Azuara-Blanco A, Dua HS. Malignant glaucoma after diode laser cyclophotocoagulation. Am J Ophthalmol. 1999;127(4):467-469. https://doi.org/:10.1016/S0002-9394 (98)00359-6.
  20. Reed JE, Thomas JV, Lytle RA, Simmons RJ. Malignant glaucoma induced by an intraocular lens. Ophthalmic Surg. 1990;21(3): 177-180.
  21. Rieser JC, Schwartz B. Miotic-induced malignant glaucoma. Arch Ophthalmol. 1972;87(6):706-712. https://doi.org/10.1001/archopht.1972.01000020708018.
  22. DiSclafani M, Liebmann JM, Ritch R. Malignant glaucoma following argon laser release of scleral flap sutures after trabeculectomy. Am J Ophthalmol. 1989;108(5):597-598. https://doi.org/10.1016/0002-9394(89)90441-8.
  23. Schwartz AL, Anderson DR. «Malignant glaucoma» in an eye with no antecedent operation or miotics. Arch Ophthalmol. 1975;93(5): 379-381. https://doi.org/10.1001/archopht.1975.01010020391015.
  24. Heatley CJ, Lim KS, Siriwardena D, et al. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide. Acta Ophthalmol Scand. 2006;84(5):712-713. https://doi.org/:10.1111/j.1600-0420.2006.00714.x.
  25. Razeghinejad MR, Amini H, Esfandiari H. Lesser anterior chamber dimensions in women may be a predisposing factor for malignant glaucoma. Medical Hypotheses. 2005;64(3):572-574. https://doi.org/10.1016/j.mehy.2004.07.035.
  26. Lois N, Wong D, Groenewald C. New surgical approach in the management of pseudophakic malignant glaucoma. Ophthalmology. 2001;108(4):780-783. https://doi.org/10.1016/S0161-6420 (00)00642-4.
  27. Faucher A, Hasanee K, Rootman DS. Phacoemulsification and intraocular lens implantation in nanophthalmic eyes. Report of a medium-size series. J. Cataract Refract. Surg. 2002;28(5):837-842.https://doi.org/10.1016/S0886-3350 (01)01161-0.
  28. Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma. 2003;12(2):167-180. https://doi.org/10.1097/00061198-200304000-00013.
  29. Yue BY, Duvall J, Goldberg MF, et al. Nanophthalmic sclera. Ophthalmology. 1986;93(4):534-541. https://doi.org/10.1016/s0161-6420(86)33704-7.
  30. Tello C, Chi T, Shepps G, et al. Ultrasound biomicroscopy in pseudophakic malignant glaucoma. Ophthalmology. 1993;100(9): 1330-1334. https://doi.org/10.1016/s0161-6420(93)31479-x.
  31. Preetha R, Goel P, Patel N, et al. Clear lens extraction with intraocular lens implantation for hyperopia. J Cataract Refract Surg. 2003;29(5): 895-899. https://doi.org/10.1016/s0886-3350(02)01979-x.
  32. Bell NP, Nagi KS, Cumba RJ, et al. Age and positional effect on the anterior chamber angle: assessment by ultrasound biomicroscopy. ISRN Ophthalmology. 2013,2013:5. https://doi.org/:10.1155/2013/706201.
  33. Wribelauer C, Karandish A, Haberle K, et al. Optical coherence tomography in malignant glaucoma following filtration surgery. Br J Ophthalmol. 2003;87(8):952-955. https://doi.org/10.1136/bjo.87.8.952.
  34. Ruben S, Tsai J, Hitchings R. Malignant glaucoma and its management. Brit J Ophthalmol. 1997;81(2):163-167. https://doi.org/org/10.1136/bjo.81.2.163.
  35. Тарасов К.Л. Комплексное профилактическое хирургическое лечение послеоперационной злокачественной глаукомы: Автореф. дис. …канд. мед. наук. – М., 2014. – 27 с. [Tarasov KL. Complex preventive surgical treatment of postoperative malignant glaucoma. [dissertation abstract] Moscow; 2014. 27 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01005559444. Ссылка активна на 15.06.2019.
  36. Wu ZH, Wang YH, Liu Y. Management strategies in malignant glaucoma secondary to antiglaucoma surgery. Int J Ophthalmol. 2016:9(1):63-68. https://doi.org/:10.18240/ijo.2016.01.11.
  37. Debrouwere V, Stalmans P, Van Calster J, et al. Outcomes of different management options for malignant glaucoma: a retrospective study. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):131-141. https://doi.org/:10.1007/s00417-011-1763-0.
  38. Rękas M, Krix-Jachym K, Żarnowski T. Evaluation of the effectiveness of surgical treatment of malignant glaucoma in pseudophakic eyes through partial PPV with establishment of communication between the anterior chamber and the vitreous cavity. J Ophthalmol. 2015;2015:1-6. https://doi.org/10.1155/2015/873124.
  39. Żarnowski T, Wilkos-Kuc A, Tulidowicz-Bielak M, et al. Efficacy and safety of a new surgical method to treat malignant glaucoma in pseudophakia. Eye (Lond). 2014;28(6):761-764. https://doi.org/ 10.1038/eye.2014.53.
  40. Tsai YY, Sengs H. Combined trabeculectomy and vitrectomy for pseudophakic malignant glaucoma and extensive peripheral anterior synechia-induced secondary glaucoma. J Cataract Refract Surg. 2004;30(3): 715-717. https://doi.org/:10.1016/S0886-3350 (03)00665-5.
  41. Francis B, Wong R, Mincler DS. Slit-lamp needle revision for aqueous misdirection after trabeculectomy. J Glaucoma. 2002;11(3): 183-188. https://doi.org/10.1097/00061198-200206000-00004.
  42. Francis BA, Babel D. Malignant glaucoma (aqueous misdirection) after pars plana vitrectomy. Ophthalmology. 2000;107(7): 1220-1222. https://doi.org/:10.1016/S0161-6420(00)00109-3.
  43. Sharma A, Sii F, Shah P, et al. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology. 2006;113(11):1968-1973. https://doi.org/10.1016/j.ophtha.2006.04.031.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Kiseleva O.A., Kosakyan S.M., Yakubova L.V., Bessmertny A.M., Vasilenkova L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies